Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy.

Authors

Andrew D Fesnak
Patrick J Hanley, George Washington UniversityFollow
Bruce L Levine

Document Type

Journal Article

Publication Date

7-31-2017

Journal

Currently Hematologic Malignant Reports

DOI

10.1007/s11899-017-0395-9

APA Citation

Fesnak, A., Hanley, P., & Levine, B. (2017). Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy.. Currently Hematologic Malignant Reports, (). http://dx.doi.org/10.1007/s11899-017-0395-9

Peer Reviewed

1